Description: Nurosene Inc., a technology-driven wellness company, focuses on developing a line of proprietary nutraceuticals in Canada. It develops nutraceuticals, including Nuro Drive, a product to enhance physical and cognitive energy levels; Nuro Restore, a product to improve sleep, as well as reduce stress, and pain and inflammation. The company is also developing a virtual care mobile application to provide continuous support to those suffering from mental health issues. Nurosene Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.
Home Page: www.nurosene.com
1655 Dupont Street
Toronto,
ON
M6P 3T1
Canada
Phone:
416 859 8838
Officers
| Name | Title |
|---|---|
| Mr. George Achilleos | CEO & Pres |
| Mr. Daniel Gallucci | Founder, Chief Performance Officer & Director |
| Mr. Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer |
| Dr. Joseph Geraci Ph.D. | Chief Scientific Officer |
| Dr. Luca Pani M.D. | Chief Innovation & Regulatory Officer and Chief Medical Advisor |
| Dr. Kaveh Kavoosi | Head of Progressive Medicine |
| Dr. Douglas James Cook M.D., Ph.D. | Chief Medical Officer |
| Mr. Mark Smithyes | Pres of NetraMark |
| Mr. Josh Spiegel | Pres of NetraMark |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3538 |
| Price-to-Sales TTM: | 77.088 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |